Increased Framingham 10-year risk of coronary heart disease in middle-aged and older patients with psychotic symptoms

Schizophrenia Research

Volumn 125, Issue 2-3, 2011, Pages 295-299

  Jin, Hua ^a,b   Folsom, David ^a,c   Sasaki, Alana ^d   Mudaliar, Sunder ^b,e   Henry, Robert ^b,e   Torres, Monique ^b   Golshan, Shah ^a,b   Glorioso, Danielle K ^a,b   Jeste, Dilip ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF HAWAII   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Framingham 10 year CHD risk; Middle aged and older patients; Psychotic disorders

Indexed keywords

ANTIDEPRESSANT AGENT; ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; ANXIOLYTIC AGENT; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MOOD STABILIZER; NEUROLEPTIC AGENT;

ADULT; AGED; AGING; ANXIETY DISORDER; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DEMENTIA; DEPRESSION; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DISEASE DURATION; EDUCATION; ETHNICITY; FEMALE; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; METABOLIC DISORDER; MIDDLE AGED; MOOD DISORDER; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; PSYCHOSIS; RISK ASSESSMENT; SCHIZOPHRENIA; SMOKING; SYSTOLIC BLOOD PRESSURE;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANTI-ANXIETY AGENTS; ANTICONVULSANTS; ANTIDEPRESSIVE AGENTS; ANTIPSYCHOTIC AGENTS; CAUSE OF DEATH; CORONARY DISEASE; DEMENTIA; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; MOOD DISORDERS; PSYCHOTIC DISORDERS; RISK; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; STRESS DISORDERS, POST-TRAUMATIC;

EID: 78951478232     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.schres.2010.10.029     Document Type: Article

References (22)

1. Alexander C.M., Landsman P.B., Teutsch S.M., Haffner S.M. Third National Health and Nutrition Examination Survey (NHANES III); National Cholesterol Education Program (NCEP). NCEP-defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50years and older. Diabetes 2003, 52(5):1210-1214. May.
2. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders IV 1994, American Psychiatric Publishing Inc., Arlington.
3. Brown S. Excess mortality of schizophrenia: a meta-analysis. Br. J. Psychiatry 1997, 171:502-508.
4. Cardenas J., Frye M.A., et al. Modal subcomponents of metabolic syndrome in patients with bipolar disorder. J. Affect. Disord. 2008, 106(1-2):91-97.
5. Casey D.E. Metabolic issues and cardiovascular disease in patients with psychiatric disorders. Am. J. Med. 2005, 118(Suppl 2):15S-22S.
6. Colton C.W., Manderscheid R.W., et al. Congruencies in increased mortality rates, years of potential life lost, and causes of death among public mental health clients in eight states. Prev. Chron. Dis. 2006, 3(2):A42.
7. D'Agostino R.B., Grundy S., Sullivan L.M., Wilson P. Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation. JAMA 2001, 286(2):180-187.
8. Daumit G.L., Goff D.C., Meyer J.M., Davis V.G., Nasrallah H.A., McEvoy J.P., Rosenheck R., Davis S.M., Hsiao J.K., Stroup T.S., Lieberman J.A. Antipsychotic effects on estimated 10-year coronary heart disease risk in the CATIE schizophrenia study. Schizophr. Res. 2008, 105(1-3):175-187.
9. Fagiolini A., Frank E., et al. Metabolic syndrome in bipolar disorder: findings from the Bipolar Disorder Center for Pennsylvanians. Bipolar Disord. 2005, 7(5):424-430.
10. Goff D.C., et al. A comparison of ten-year cardiac risk estimates in schizophrenia patients from the CATIE study and matched controls. Schizophr. Res. 2005, 80(1):45-53.
11. Heiskanen T.H., Niskanen L.K., et al. Metabolic syndrome and depression: a cross-sectional analysis. J. Clin. Psychiatry 2006, 67(9):1422-1427.
12. Heppner Pia S., Crawford Eric F., Haji Uzair A., Afari Niloofar, Hauger Richard L., Dashevsky Boris A., Horn Paul S., Nunnink Sarah E., Baker Dewleen G. The association of posttraumatic stress disorder and metabolic syndrome: a study of increased health risk in veterans. BMC Med. 2009, 7:1.
13. Isomaa B., Almgren P., Tuomi T., Forsén B., Lahti K., Nissén M., Taskinen M.R., Groop L. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diab. Care 2001, 24(4):683-689. Apr.
14. Jakovljevic M., Crncevic Z., et al. Mental disorders and metabolic syndrome: a fatamorgana or warning reality?. Psychiatr. Danub. 2007, 19(1-2):76-86.
15. Jin H., Meyer J.M., et al. Atypical antipsychotics and glucose dysregulation: a systematic review. Schizophr. Res. 2004, 71(2-3):195-212.
16. Jin H., et al. Association of post-traumatic stress disorder with increased prevalence of metabolic syndrome. J. Clin. Psychopharmacol. 2009, 29(3):210-215.
17. McEvoy J.P., Meyer J.M., et al. Prevalence of the metabolic syndrome in patients with schizophrenia: baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES III. Schizophr. Res. 2005, 80(1):19-32.
18. Miller M.D., Paradis C.F., Houck P.R., Mazumdar S., Stack J.A., Rifai A.H., Mulsant B., Reynolds C.F. Rating chronic medical illness burden in geropsychiatric practice and research: application of the Cumulative Illness Rating Scale. Psychiatry Res. 1992, 41(3):237-248.
19. Osby U., Correia N., Brandt L., Ekbom A., Sparen P. Time trends in schizophrenia mortality in Stockholm county, Sweden: cohort study. BMJ 2000, 321:483-484.
20. Wilson P.W., D'Agostino R.B., Levy D., Belanger A.M., Silbershatz H., Kannel W.B. Prediction of coronary heart disease using risk factor categories. Circulation 1998, 97(18):1837-1847.
21. Wirshing D.A., Boyd J.A., et al. The effects of novel antipsychotics on glucose and lipid levels. J. Clin. Psychiatry 2002, 63(10):856-865.
22. http://www.framinghamheartstudy.org/risk/coronary.html.